For IPO Boutique's "scale of 1 to 5" BUY rating on Trevi Therapeutics Inc, and our comprehensive analysis, click "Buy Market Research".
Trevi Therapeutics Inc Quote & Chart - Click for current quote - TRVI
About Trevi Therapeutics Inc (adapted from Trevi Therapeutics Inc prospectus): They are a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis and prurigo nodularis.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TRVI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
